...
首页> 外文期刊>Smart nanocomposites >Smart Titanium Dioxide Nanocomposites for Cellular Delivery of the Antisense Peptide Nucleic Acids
【24h】

Smart Titanium Dioxide Nanocomposites for Cellular Delivery of the Antisense Peptide Nucleic Acids

机译:智能二氧化钛纳米复合材料的反义肽核酸细胞输送。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Peptide nucleic acids (PNAs) are one of the promising antisense drugs for the gene therapy. PNAs are DNA mimics with the peptide-like backbone [1]. PNAs form the most stable complementary duplexes with RNA among all known modified and non-modified oligonucleotides and have high exo- and endonuclease resistance [2, 3]. However, PNAs themselves cannot penetrate through cellular membranes [4]. Here we propose to use nanocomposites based on titanium dioxide (TiO_2) nanoparticles for the delivery of PNAs into living cells.After delivery of antisense PNA drugs into the cells there is still a problem with PNA molecules release from nanocomposite vehicles in cytoplasm inside of cells. Here we designed special nanocomposites on the basis of TiO_2 nanoparticles (4-6 nm in diameter) containing the hybrid PNADNA duplexes. The attachment of PNADNA duplexes to nanoparticles preliminary covered with polylysine (PL) occurs due to the electrostatic interaction between negatively charged internucleotide phosphate groups of DNA and positively charged amino groups of polylysine. It was demonstrated that the resulted TiO_2/PL/DNA/PNA nanocomposite can be delivered into the cells. Dissociation or release time of PNA from the DNA/PNA duplex attached to the nanocomposite was measured and easily could be regulated with the length of the overlap of complementary base pairs in the initially constructed DNA/PNA duplexes in nanocomposite TiO_2/PL/DNA/PNA. Thus, PNA/DNA complex with optimal overlap number or optimal half-release time of PNA from nanocomposite allows at least the half quantity of PNA still to remain in TiO_2/PL/DNA/PNA nanocomposite during the delivery and then able to be released from the nanocomposite after its delivery inside of the cells. These features of the constructed nanocomposites were demonstrated on the example of nanocomposites containing various overlap length of DNA/PNA duplexes (from 10 to 16 base pairs). It was found that the time of half-release of PNA from these TiO_2/PL/DNA/PNA nanocomposites changed from 10 to 70 min depended on overlap length of DNA/PNA duplexes in conditions close to physiological (35℃ in PBS buffer, pH 7.5). The greater the overlap of the DNA/PNA duplex in nanocomposite TiO_2/PL/DNA/PNA, the longer the time of PNA release from this nanocomposite. Thus, the adjustable reversible method of PNA immobilization on TiO_2 nanoparticles was developed. Created PNA containing nanocomposites were capable to penetrate cell membranes without transfectants or other adverse procedures.
机译:肽核酸(PNA)是用于基因治疗的有前途的反义药物之一。 PNA是具有肽样骨架的DNA模拟物[1]。在所有已知的修饰和未修饰的寡核苷酸中,PNA与RNA形成最稳定的互补双链体,并具有高的核酸外切酶和核酸内切酶抗性[2,3]。但是,PNA本身无法穿透细胞膜[4]。在这里,我们建议使用基于二氧化钛(TiO_2)纳米粒子的纳米复合材料将PNA传递到活细胞中。在将反义PNA药物传递到细胞中后,细胞内部细胞质中纳米复合载体释放的PNA分子仍然存在问题。在这里,我们基于包含杂化PNADNA双链体的TiO_2纳米颗粒(直径为4-6 nm)设计了特殊的纳米复合材料。 PNADNA双链体附着到初步被聚赖氨酸(PL)覆盖的纳米颗粒上是由于DNA的带负电荷的核苷酸间磷酸基团与聚赖氨酸的带正电荷的氨基之间的静电相互作用。结果表明,所得的TiO_2 / PL / DNA / PNA纳米复合材料可以传递到细胞中。测量了PNA从附着在纳米复合材料上的DNA / PNA双链体的解离或释放时间,可以很容易地用纳米复合材料TiO_2 / PL / DNA / PNA中最初构建的DNA / PNA双链体中互补碱基对的重叠长度来调节。 。因此,具有最佳重叠数或最佳PNA从纳米复合材料的半释放时间的PNA / DNA复合物,至少有一半的PNA在递送过程中仍保留在TiO_2 / PL / DNA / PNA纳米复合物中,然后能够从纳米复合物中释放出来。纳米复合材料在细胞内传递后。在包含DNA / PNA双链体的各种重叠长度(10至16个碱基对)的纳米复合材料的实例上证明了构建的纳米复合材料的这些特征。结果发现,这些TiO_2 / PL / DNA / PNA纳米复合物中PNA的半释放时间从10分钟改变为70分钟,取决于DNA / PNA双链体在接近生理条件(在PBS缓冲液中,温度为35℃,pH 7.5)。纳米复合材料TiO_2 / PL / DNA / PNA中DNA / PNA双链体的重叠越大,则PNA从纳米复合物中释放的时间越长。因此,开发了可调整的可逆的PNA固定在TiO_2纳米粒子上的方法。创建的含有PNA的纳米复合材料能够穿透细胞膜而无需转染子或其他不利程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号